Cargando…
Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer
Prostate cancer is one of the most common malignancies in men. Over time, it can metastasize and become lethal once it exhausts hormonal therapies and transitions into castration-resistant prostate cancer (CRPC). Several therapies have been recently approved for advanced prostate cancer, but identif...
Autores principales: | Jang, Albert, Rauterkus, Grant P, Vaishampayan, Ulka N, Barata, Pedro C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427206/ https://www.ncbi.nlm.nih.gov/pubmed/36051571 http://dx.doi.org/10.2147/OTT.S285758 |
Ejemplares similares
-
Development of cabozantinib for the treatment of prostate cancer
por: Vaishampayan, Ulka N
Publicado: (2014) -
Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021) -
Immunotherapy and Immune Evasion in Prostate Cancer
por: Thakur, Archana, et al.
Publicado: (2013) -
Overcoming Obstacles
por: Braile, Domingo M.
Publicado: (2015) -
Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
por: Wong, Han Hsi, et al.
Publicado: (2010)